TABLE OF CONTENTS
Volume 28, Issue 12 (December 2003)
Original Articles
Topographical Assessment of Ethological and Dopamine Receptor Agonist-Induced Behavioral Phenotype in Mutants with Congenic DARPP-32 'Knockout' FREE
Rachel E Nally, Fergal N McNamara, Jeremiah J Clifford, A Kinsella, Orna Tighe, David T Croke, Allen A Fienberg, Paul Greengard and John L Waddington
Neuropsychopharmacology 28: 2055-2063; advance online publication, July 16, 2003; doi:10.1038/sj.npp.1300259
SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile FREE
Yves Claustre, Danielle De Peretti, Philippe Brun, Christiane Gueudet, Nathalie Allouard, Richard Alonso, Joëlle Lourdelet, André Oblin, Gabrielle Damoiseau, Dominique Françon, Marie-Françoise Suaud-Chagny, Régis Steinberg, Mireille Sevrin, Hans Schoemaker, Pascal George, Philippe Soubrié and Bernard Scatton
Neuropsychopharmacology 28: 2064-2076; advance online publication, August 6, 2003; doi:10.1038/sj.npp.1300262
Mice Lacking the Serotonin Transporter Exhibit 5-HT1A Receptor-Mediated Abnormalities in Tests for Anxiety-like Behavior FREE
Andrew Holmes, Rebecca J Yang, Klaus-Peter Lesch, Jacqueline N Crawley and Dennis L Murphy
Neuropsychopharmacology 28: 2077-2088; advance online publication, September 10, 2003; doi:10.1038/sj.npp.1300266
Individual Differences in Cocaine-induced Locomotor Activity in Rats: Behavioral Characteristics, Cocaine Pharmacokinetics, and the Dopamine Transporter FREE
Joshua M Gulley, Brian R Hoover, Gaynor A Larson and Nancy R Zahniser
Neuropsychopharmacology 28: 2089-2101; advance online publication, August 6, 2003; doi:10.1038/sj.npp.1300279
Effects of Cocaine in Rats Exposed to Heroin FREE
Francesco Leri, Joseph Flores, Heshmat Rajabi and Jane Stewart
Neuropsychopharmacology 28: 2102-2116; advance online publication, September 10, 2003; doi:10.1038/sj.npp.1300284
The Pineal Gland is Critical for Circadian Period1 Expression in the Striatum and for Circadian Cocaine Sensitization in Mice FREE
Tolga Uz, Mustafa Akhisaroglu, Rehan Ahmed and Hari Manev
Neuropsychopharmacology 28: 2117-2123; advance online publication, July 9, 2003; doi:10.1038/sj.npp.1300254
The Reinforcing Properties of Alcohol are Mediated by GABAA1 Receptors in the Ventral Pallidum FREE
Harry L June, Katrina L Foster, Peter F McKay, Regat Seyoum, James E Woods II, Scott C Harvey, William J A Eiler II, Collette Grey, Michelle R Carroll, Shannan McCane, Cecily M Jones, Wenyuan Yin, Dynesha Mason, Rancia Cummings, Marin Garcia, Chunrong Ma, P V V S Sarma, James M Cook and Phil Skolnick
Neuropsychopharmacology 28: 2124-2137; advance online publication, September 10, 2003; doi:10.1038/sj.npp.1300239
Differential Role of Serotonergic Projections Arising from the Dorsal and Median Raphe Nuclei in Locomotor Hyperactivity and Prepulse Inhibition FREE
Snezana Kusljic, David L Copolov and Maarten van den Buuse
Neuropsychopharmacology 28: 2138-2147; advance online publication, July 30, 2003; doi:10.1038/sj.npp.1300277
Altered Serotonergic Neurotransmission but Normal Hypothalamic–Pituitary–Adrenocortical Axis Activity in Mice Chronically Treated with the Corticotropin-Releasing Hormone Receptor Type 1 Antagonist NBI 30775 FREE
Akihiko Oshima, Cornelia Flachskamm, Johannes M H M Reul, Florian Holsboer and Astrid C E Linthorst
Neuropsychopharmacology 28: 2148-2159; advance online publication, August 13, 2003; doi:10.1038/sj.npp.1300267
Hyperforin-Containing Extracts of St John's Wort Fail to Alter Gene Transcription in Brain Areas Involved in HPA Axis Control in a Long-Term Treatment Regimen in Rats FREE
Veronika Butterweck, Hilke Winterhoff and Miles Herkenham
Neuropsychopharmacology 28: 2160-2168; advance online publication, July 16, 2003; doi:10.1038/sj.npp.1300253
Pharmacological and Nonpharmacological Factors Influencing Hypothalamic–Pituitary–Adrenocortical Axis Reactivity in Acutely Depressed Psychiatric In-patients, Measured by the Dex-CRH Test FREE
H E Künzel, E B Binder, T Nickel, M Ising, B Fuchs, M Majer, A Pfennig, G Ernst, N Kern, D A Schmid, M Uhr, F Holsboer and S Modell
Neuropsychopharmacology 28: 2169-2178; advance online publication, August 20, 2003; doi:10.1038/sj.npp.1300280
Left Orbital Frontal Cortex Volume and Performance on the Benton Visual Retention Test in Older Depressives and Controls FREE
David C Steffens, Douglas R McQuoid, Kathleen A Welsh-Bohmer and K Ranga Rama Krishnan
Neuropsychopharmacology 28: 2179-2183; advance online publication, October 8, 2003; doi:10.1038/sj.npp.1300285
Effects of Nicotine on Leading Saccades during Smooth Pursuit Eye Movements in Smokers and Nonsmokers with Schizophrenia FREE
Matthew T Avila, Jay D Sherr, Elliot Hong, Carol S Myers and Gunvant K Thaker
Neuropsychopharmacology 28: 2184-2191; advance online publication, September 10, 2003; doi:10.1038/sj.npp.1300265
Positron Emission Tomography Studies of Potential Mechanisms Underlying Phencyclidine-Induced Alterations in Striatal Dopamine FREE
Wynne K Schiffer, Jean Logan and Stephen L Dewey
Neuropsychopharmacology 28: 2192-2198; advance online publication, July 23, 2003; doi:10.1038/sj.npp.1300258
Effects of Procyclidine on Eye Movements in Schizophrenia FREE
Ulrich Ettinger, Veena Kumari, Elizabeth Zachariah, Adrian Galea, Trevor J Crawford, Philip J Corr, David Taylor, Mrigendra Das and Tonmoy Sharma
Neuropsychopharmacology 28: 2199-2208; advance online publication, August 27, 2003; doi:10.1038/sj.npp.1300286
Letter to the Editor
H1-histamine Receptor Affinity Predicts Short-term Weight Gain for Typical and Atypical Antipsychotic Drugs FREE
Andrew J Goudie, Jason C G Halford, Terry M Dovey, Gillian D Cooper and Joanna C Neill
Neuropsychopharmacology 28: 2209; advance online publication, August 27, 2003; doi:10.1038/sj.npp.1300291
Correspondence
Reply to Andrew J Goudie et al
Reply: H1-histamine Receptor Affinity Predicts Short-term Weight Gain for Typical and Atypical Antipsychotic Drugs FREE
Wesley K Kroeze, Sandra J Hufeisen, Beth A Popadak, Sean M Renock, SeAnna Steinberg, Paul Ernsberger, Karu Jayathilake, Herbert Y Meltzer and Bryan L Roth
Neuropsychopharmacology 28: 2210-2211; advance online publication, August 27, 2003; doi:10.1038/sj.npp.1300292
Letter to the Editor
L-Tryptophan Challenge and Cognitive Deficits in Bipolar Disorder: Evidence for Hyperserotonergic and Hypodopaminergic Mechanisms FREE
Pradeep J Nathan and Ben J Harrison
Neuropsychopharmacology 28: 2212-2213; advance online publication, July 30, 2003; doi:10.1038/sj.npp.1300269
Correspondence
Reply to Pradeep J Nathan and Ben J Harrison
Reply: Pronounced Cognitive Deficits Following an Intravenous L-Tryptophan Challenge in First-degree Relatives of Bipolar Patients Compared to Healthy Controls FREE
S Sobczak, A Honig and Wim J Riedel
Neuropsychopharmacology 28: 2214-2216; advance online publication, September 10, 2003; doi:10.1038/sj.npp.1300270
Corrigendum
Comparison of Cognitive Peformances During a Placebo Period and an Atypical Antipsychotic Treatment Period in Schizophrenia: Critical Examination of Confounds FREE
Thomas W Weickert, Terry E Goldberg, Stefano Marenco, Llewellyn B Bigelow, Michael F Egan and Daniel R Weinberger
Neuropsychopharmacology 28: 2217; doi:10.1038/sj.npp.1300349
Obituaries
Patricia Goldman-Rakic, 1937–2003 FREE
George Aghajanian, Benjamin S Bunney and Philip S Holzman
Neuropsychopharmacology 28: 2218-2220; doi:10.1038/sj.npp.1300325
